Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.36), in-line with the analyst estimate of ($0.36).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.